Brief: Evotec Receives Two Gates Foundation Grants For TB Totaling $9.9 Million
April 30 (Reuters) - EVOTEC SE EVTG.DE: RECEIVES TWO GATES FOUNDATION GRANTS FOR TB TOTALING $9.9 MILLION FIRST GRANT SUPPORTS DISCOVERY OF NOVEL SMALL MOLECULES FOR TB SECOND GRANT ENABLES NONCLINICAL CHARACTERIZATION OF NEXT-GEN TB DRUG COMBINATIONS Source text: ID:nEQ1wgnQNa Further company coverage: EVTG.DE (Gdansk Newsroom) ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases